Icatibant Injection, Solution
Product Images NDC 55150-351
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 55150-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 Time To 50% Reduction From Baseline In 3-item Vas Score (Icatibant Fig1)
Figure A (Icatibant Fig2)
Figure B (Icatibant Fig3)
Figure C (Icatibant Fig4)
Figure D (Icatibant Fig5)
Figure E (Icatibant Fig6)
Figure F (Icatibant Fig7)
Figure G (Icatibant Fig8)
Figure H (Icatibant Fig9)
Figure I (Icatibant Fig10)
Figure J (Icatibant Fig11)
Figure K (Icatibant Fig12)
Figure L (Icatibant Fig13)
Figure M (Icatibant Fig14)
Figure N (Icatibant Fig15)
Figure O (Icatibant Fig16)
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syrine Label)
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe Carton (1 Syringe))
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe-Carton (3 Syringes))
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.